Prolactin receptor signal transduction

Lupus

Volumn 10, Issue 10, 2001, Pages 706-718

  Clevenge, C V ^a   Kline, J B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Guanine nucleotide exchange factor; Phosphatase; Phosphorylation; Protein tyrosine kinase; Protein protein interactions

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; LIGAND; PHOSPHATASE; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN TYROSINE KINASE;

HUMAN; IMMUNE SYSTEM; LIGAND BINDING; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; GENE EXPRESSION PROFILING; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION;

EID: 0034757830     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301717164949     Document Type: Review

References (149)

1. Structural design and molecular evolution of a cytokine receptor superfamily
2. Haematopoietic receptors and helical cytokines
3. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
4. Prolactin as an autocrine/paracrine growth factor in breast tissue
5. Prolactin receptor signal transduction in cells of the immune system
6. Lactogenic hormone signal transduction
7. Real-time measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model hormone-induced transient receptor dimerization
8. Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells
9. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract
10. Expression of prolactin and prolactin receptor in human breast carcinoma: Evidence for an autocrine/paracrine loop
11. Functional characterization of the intermediate isoform of the human prolactin receptor
12. Identification and characterization of the prolactin-binding protein (PRLBP) in human serum and milk
13. Expression of two forms of prolactin receptor in rat ovary and liver
14. The X-ray structure of a growth hormone-prolactin receptor complex
15. Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction
16. Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common beta subunit responsible for different signaling
17. Interleukin 7 receptor functions by recruiting tyrosine kinase p59fyn through a segment of its cytoplasmic tail
18. Tyrosine docking sites of the rat prolactin receptor required for association and activation Stat5
19. Recruitment of the protein-tyrosine phosphatase SHP-2 to the C-terminal tyrosine of the prolactin receptor and to the adaptor protein Gab2
20. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation
21. Characterization of a novel and functional human prolactin receptor isoform (ΔS1PRLr) containing only one fibronectin-like domain
22. Cloning, expression, and mutational analysis of the pigeon prolactin receptor
23. Double antenna structure of chicken prolactin receptor deduced from the cDNA sequence
24. Characterization of unique truncated prolactin receptor transcripts, corresponding to the intracellular domain, in the testis of the sexually mature chicken
25. Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites
26. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat
27. Tissue distribution and regulation of rat prolactin receptor gene expression
28. Changes in prolactin receptor expression during pregnancy in the mouse ovary
29. Modulation of growth factor receptor function by isoform heterodimerization
30. Cytokine receptor signaling
31. Jaks and Stats in signaling by the cytokine receptor superfamily
32. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
33. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
34. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants
35. Activation of receptor-associated tyrosine kinase JAK2 by prolactin
36. Jak2 is essential for signaling through a variety of cytokine receptors
37. c chain
38. Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphod cells
39. Prolactin-induced proliferation Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2
40. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced β-lactoglobulin transcription
41. Critical role of the interleukin 2 (IL2) receptor gamma-chain associated Jak3 in the IL-2 induced c-fos and c-myc, but not bcl-2 gene, induction
42. The protein tyrosine kinase Jak1 complements defects in interferon-alpha/beta and -gamma signaling
43. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction
44. The last proline of box 1 is essential for association with JAK2 and functional activation of the prolactin receptor
45. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription
46. Prolactin signal transduction to milk protein genes: Carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation
47. Stoichiometric structure/function analysis of the prolactin receptor signaling domains by receptor chimeras
48. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins
49. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase
50. 1007 in the kinase activation loop
51. In vitro expression of long and short ovine prolactin receptors: Activation of Jak2/STAT5 pathway is not sufficient to account for prolactin signal transduction to the ovine β-lactoglobulin promoter
52. Stimulation of c-Src by prolactin is independent of Jak2
53. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515, and TYR580
54. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways
55. Molecular characterization of specific interactions between SHP-2 phosphatase and Jak tyrosine kinases
56. Tec and Jak2 kinases cooperate to mediate cytokine-driven activation of c-fos transcription
57. SHP-2, SH2-containing protein tyrosine phosphatase-2
58. Immune signalling: SHP-2 docks at multiple ports
59. PTPID is a positive regulator of the prolactin signal leading to β-casein promoter activation
60. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 and induction of Stat5-dependent transcription
61. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain containing protein tyrosine phosphatase SHP-2 in response to mitogens and adhesion
62. SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages
63. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association
64. Negative regulation of cytokine signaling: STAT-induced Stat inhibitor
65. Negative regulation of the JAK/STAT pathway
66. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling
67. SOCS: Suppressors of cytokine signaling
68. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling
69. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
70. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
71. fyn is associated with prolactin receptor and is activated by prolactin stimulation of T-lymphocytes
72. c-src family of protein-tyrosine kinases
73. Protein tyrosine kinases, with emphasis on the Src family
74. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases
75. Prolactin receptor is associated with c-Src in rat liver
76. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A
77. Lck phosphorylates the activaiton loop tyrosine of the ltk kinase domain and activates Itk kinase activity
78. Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells
79. Prolactin induced tyrosine phosphorylation of p59fyn may mediate phosphatidyinositol 3-kinase activation in Nb2 cells
80. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase
81. Protein tyrosine kinases in the initiation of antigen receptor signaling
82. The PH domain: A common piece in the structural patchwork of signalling proteins
83. Tec homology (TH) adjacent to the PH domain
84. Tec protein kinase directly associates with Lyn protein tyrosine kinase through its N-terminal unique domain
85. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain
86. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through Jak
87. Tec protein kinase is involved in the signaling mechanism of granulocyte colony-stimulating factor receptor
88. Engagement of the Tcr/CD3 complex stimulates p59fyn activity: Detection of associated proteins at 72 and 120-130 KD
89. Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Gα12/13
90. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line
91. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: Mapping of a Tec/Vav1-receptor binding site
92. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases
93. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase
94. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling
95. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line
96. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the Vav proto-oncogene product
97. Functional and physical interactions of syk family kinases with the vav proto-oncogene product
98. Phosphorylation- and activation-independent association of the tyrosine kinase Syk and the tyrosine kinase substrates Cbl and Vav with tubulin in B-cells
99. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vavl
100. fyn tyrosine kinase with murine T lymphoma membrane phophoproteins
101. Lck regulates Vav activation of members of the Rho family of GTPases
102. Developmental expression of the vav proto-oncogene
103. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates
104. Mechanism of activation of the vav protooncogene
105. Single point mutation in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav
106. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells
107. Tyrosine-kinase stimulated guanine nucleotide exchange activity of vav in T cell activation
108. Tyrosine phosphorylation and activation of vav GTP/GDP exchange activity in Antigen receptor-triggered B cells
109. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
110. Interferon α induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells
111. vav. in human hematopoietic cells
112. Direct stimulation of vav guanine nucleotide exchange activity for ras by phorbol esters and diglycerides
113. Interleukin-2 induces tyrosine phophorylation of the vav proto-oncogene product in human T cells: Lack of requirement for the tyrosine kinase lck
114. Defective signalling through the T- and B-Cell antigen receptors in lymphoid cells lacking the vav proto-oncogene
115. Biological and regulatory properties of Vav-3, an new member of the Vav family of oncoproteins
116. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2
117. Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav
118. 2 terminal sequences in the negative regulation of Vav signaling and transforming activity
119. Role of substrates and products of PI 3-kinase in regulating activation of rac-related guanosine triphosphatases by Vav
120. Coupling of ras and rac guanosine triphosphatases through the ras exchanger Sos
121. Role of phosphoinositide-3-OH kinase in ras signaling
122. Phosphotidylinositol-3-OH kinase as a direct target of Ras
123. Rho GTPases and the actin cytoskeleton
124. GTPases in antigen receptor signalling
125. Effectors for the Rho GTPases
126. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor
127. Defects in actin-cap formation in Vav-defecient mice implicate an actin requirement for lymphocyte signal transduction
128. Rho, rac, and cdc42 regulate actin organization and cell adhesion in macrophages
129. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions
130. Signal transduction and actin filament organization
131. Integrins and GTPases in tumour cell growth, motility and invasion
132. Prolactin as a chemoattractant for human breast carcinoma
133. Prolactin receptor signaling: Shared components with the T-cell antigen receptor in Nb2 lymphoma cells
134. Regulation of Vav-SLP binding by ZAP-70 and its relevance to TCRζ/CD3 induction interleukin-2
135. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1/PAK-1/p38 MAPK signaling pathway
136. Prolactin stimulates phosphorylation of the human T-cell antigen receptor complex and ZAP-70 tyrosine kinase: A potential for immunomodulation
137. Prolactin induces rapid phosphorylation and activation of prolactin receptor associated Raf-1 kinase in a T-cell line
138. Effect of PRL on MAPK activation negative regulatory role of the C-terminal part of the PRL receptor
139. Involvement of SHC, GRB2, SOS, and RAS in prolactin signal transduction in mammary epithelial cells
140. Signal transduction within the nucleus by mitogen-activated protein kinase
141. The role of the PH domain in the signal-dependent membrane targeting of Sos
142. Specific and high-affinity binding of inositolphosphates to an isolated pleckstrin homology domain
143. Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase
144. Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen
145. Prolactin activates protein kinase C and stimulates growth-related expression in rat liver
146. Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells
147. Prolactin stimulation of ornithine decarboxylase and mitogensis in NB2 node lymphoma cells: The role of protein kinase C and calcium mobilization
148. Role of calcium in prolactin-stimulated c-myc gene expression and mitogenesis in NB2 lymphoma cells
149. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK and AP-1 activation: Inhibition by glucocorticoids